Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 1956356-56-1 Chemical Structure| 1956356-56-1

Structure of KYA1797K
CAS No.: 1956356-56-1

Chemical Structure| 1956356-56-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

KYA1797K serves as a potent and selective inhibitor of the Wnt/β-catenin pathway, with an IC50 of 0.75 µM.

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of KYA1797K

CAS No. :1956356-56-1
Formula : C17H11KN2O6S2
M.W : 442.51
SMILES Code : O=C([O-])CCN(C/1=O)C(SC1=C\C2=CC=C(C3=CC=C([N+]([O-])=O)C=C3)O2)=S.[K+]
English Name :Potassium (Z)-3-(5-((5-(4-nitrophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)propanoate (1:1)
MDL No. :MFCD30718585
InChI Key :PHUNRLYHXGMOLG-WQRRWHLMSA-M
Pubchem ID :119057297

Safety of KYA1797K

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
CRC cells 25 µM 3 to 7 days Effectively suppressed the stemness of CSCs Cell Commun Signal. 2020 Mar 6;18(1):38.
TNBC cells 5 or 25 µM 24 hours KYA1797K downregulates β-catenin, RAS, and EGFR and suppresses proliferation and colony formation. Exp Mol Med. 2020 May;52(5):832-842.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Athymic nu/nu mice Tumor xenograft model Intraperitoneal injection 20 mg/kg Once daily for 21 days To test the effect of KYA1797K on tumor growth, results showed that KYA1797K significantly reduced tumor volume and weight. Exp Mol Med. 2018 Nov 20;50(11):1-12
Mice ApcMin/+ /KrasG12DLA2 mice Intraperitoneal injection 25 mg/kg 5 days per week for 7 weeks Suppressed tumor growth and reduced stemness of CSCs Cell Commun Signal. 2020 Mar 6;18(1):38.
Mice TNBC PDX tumors Intraperitoneal injection 25 mg/ml Daily until tumor size reached between 150 and 200 mm3 KYA1797K suppressed the growth of TNBC PDX tumors. Exp Mol Med. 2020 May;52(5):832-842.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.26mL

0.45mL

0.23mL

11.30mL

2.26mL

1.13mL

22.60mL

4.52mL

2.26mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories